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Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive and malignant tumor that is charac-
terized by nests of small tumor cells surrounded by a cellular and vascular collagenous stroma and
predominantly affects young adolescent males. This tumor most commonly originates in the abdomen;
however, in rare cases, DSRCT can originate in other body regions. The main manifestations of DSRCT are
chest pain and respiratory symptoms, and patients' average survival after diagnosis is less than two
years. In this report, we describe a case involving DSRCT of the lung that proved to be difﬁcult to di-
agnose, and we conduct a literature review.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Desmoplastic small round cell tumor (DSRCT) was ﬁrst
described by Gerald and Rosai in 19891 as a distinct tumor with
speciﬁc histological and immunohistochemical patterns and chro-
mosomal translocation [1e3]. DSRCT is a rare, aggressive, malig-
nant tumor that predominantly affects young males, with a median
patient age of 19 years and reported male-to-female ratios ranging
from 5:1 to 10:1 [4,5]. No standard therapy is currently available for
patients with DSRCT, and the prognosis for DSRCT remains
extremely poor5. DSRCT is a member of the small round blue cell
tumor family, which includes small-cell carcinoma, Merkel cell
carcinoma, synovial sarcoma, Ewing's sarcoma/primitive neuro-
ectodermal tumor, neuroblastoma, lymphoma, and rhabdomyo-
sarcoma [6]. Due to the rarity of DSRCT and the absence of speciﬁc
clinical manifestations of this tumor, clinicians may overlook theor, DSRCT; Lactate dehydro-
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arises in the thorax. The main manifestations of DSRCT are chest
pain and respiratory symptoms [7]. In this report, we present a case
of a young female who was diagnosed with DSRCT of the lung that
rapidly produced a fatal outcome, and we review relevant
literature.2. Case report
A 21-year-old female was admitted to our hospital after 3 weeks
of marked general symptoms (asthenia, hyporexia and weight loss
of 5 kg) accompanied by left chest pain, low-grade fever and
shortness of breath on exertion. The patient had no known toxic
habits and no signiﬁcant medical or family history. On clinical ex-
amination, the patient was hemodynamically stable and apyrexic,
with an oxygen saturation of 93% while inspiring room air.
Auscultation of the chest revealed inaudible breath sounds in the
left thorax. The remaining ﬁndings from general physical and sys-
temic examinations were essentially normal. Initial investigations
revealed a hemoglobin level of 11.6 gm/dL, a white cell count of
13,680/mL with 80% neutrophils, and a normal platelet count. The
patient's serum lactate dehydrogenase (LDH) was 420 U/L. The
remaining biochemical parameters were essentially normal. An
enzyme-linked immunosorbent assay (ELISA) for human immu-
nodeﬁciency virus (HIV) was non-reactive. A chest X-ray (Fig. 1)
revealed a large left pleural effusion.
A diagnostic thoracentesis was performed, and analysis of the
pleural ﬂuid revealed 620 cells, with a differential count of 85%nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Chest X-ray depicting a left pleural effusion.
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the pleural ﬂuid were 50 mg/dL and 3.4 gm/dL, respectively. Serum
proteinwas 6.5 gm/dL. The adenosine deaminase (ADA) level in the
pleural ﬂuid was 32 U/L. Pleural ﬂuid cytology was positive for
malignant cells. A closed pleural biopsy revealed tumor inﬁltration
by a small round monomorphous cell; however, we were unable to
identify a clear lineage in the pathological anatomy. A computed
tomography (CT) scan (Fig. 2) revealed a large left pulmonary mass
that inﬁltrated the left pulmonary artery, left main bronchus and
main carina as well as a severe pericardial effusion that was pri-
marily localized around the left ventricle. A large subcarinal
adenopathy was observed. No abdominal or pelvic abnormalities
were found.
A bronchoscopy (Fig. 3) revealed a whitish exophytic lesion that
almost completely obstructed the left main bronchus. Bronchial
biopsies of themass and transbronchial needle aspiration (TBNA) of
the subcarinal adenopathy were performed. The results suggested a
malignant low-grade tumor of possible mesenchymal origin with
an uncertain immunohistochemical proﬁle (with tumor cells
negative for vimentin, desmin, neuron-speciﬁc enolase, epithelial
membrane antigen, synaptophysin, S-100, CD117, CD31, CD5 and
CD20 and positive only for CD34).
Tumormarkers werewithin normal limits, with the exception of
CA-125, which was elevated. On the 7th day after admission, the
patient began to experience extremely intense, continuous left
shoulder pain that exhibited neuropathic characteristics. Brachial
plexus inﬁltration was suspected; however, due to the patient's
intolerance of the supine position, an MRI could not be performed.
Due to the absence of a deﬁnitive histological diagnosis, the patient
was subjected to an open lung biopsy. During this procedure, she
exhibited cardiac tamponade and was admitted to the ICU with
acute respiratory failure and cardiogenic shock. Unfortunately, the
patient died 24 h later.Fig. 2. CT scan depicting a large left pulmonary mass inﬁltrating the left pulmonary arter
primarily localized around the left ventricle. An enlarged subcarinal lymph node is also visThe family agreed to an autopsy. At the macroscopic level
(Fig. 4), the autopsy revealed a tumor mass with large dimensions
that weighed 1750 g. The tumor was exclusively intrathoracic, it
occupied the entire left hemithorax; surrounded and inﬁltrated the
left main bronchus and left great vessels; was ﬁrmly adhered to the
chest wall, diaphragm, pericardium, and left atrium wall; and had
pushed the heart to the right side. Microscopically (Fig. 5), an
intense inﬁltrate of undifferentiated tumor cells with extensive
mitosis was observed. Immunohistochemical assessments indi-
cated that tumor cells were negative for leukocyte common antigen
(LCA), cytokeratin, neuron-speciﬁc enolase, synaptophysin, smooth
muscle actin (SMA), CD1, S-100, CD15, chromogranin, CD57 and
CD99 but strongly expressed CK7, 34B12, desmin and vimentin
(Fig. 6). This pattern conﬁrmed the diagnosis of DSRCT. Polymerase
chain reaction (PCR) analysis to detect the t(11; 22) (p13; q12)
translocation produced negative results.
3. Discussion
DSRCT is a rare but aggressive tumor. DSRCT was ﬁrst described
in 1989 by Gerald and Rosai, who noticed a distinctive type of small
cell tumor that predominantly involved the abdomen and affected
young males [1]. The prognoses of patients with DSRCT have not
substantially improved since this disease was ﬁrst described. This
tumor is known as a desmoplastic small round cell tumor because
DSRCT is characterized by nests of small tumor cells surrounded by
a cellular and vascular collagenous stroma. Although this stroma is
always observed, its quantity varies with tumor progression [1,6].
More than 100 cases of DSRCT of the peritoneum have been re-
ported in English-language publications [1,3,6]. Other reported
sites of DSRCT include the tunica vaginalis testis, skull, parotid
gland, hand, uterine serosal surface, ovarian surface, and urogenital
region [7,8]. To date, 7 cases of DSRCT in the thoracic cavity have
been described, although the tumor was conﬁned to the thorax in
only one of these cases [6,7,9]. The present paper describes the
second case of DSRCT conﬁned to the thorax that has been reported
in the literature.
Pathologically, DSRCT consists of round, blue cells embedded in
a desmoplastic stroma. Immunohistochemical markers are used to
distinguish DSRCT from other small cell tumors. Ordonez assessed a
variety of epithelial, mesenchymal, and neuronal markers in 39
tumors and detected cytokeratin in 37/39 tumors, epithelial
membrane antigen in 24/25 tumors, desmin in 39/39 tumors,
vimentin in 22/27 tumors, neuron-speciﬁc enolase in 18/25 tumors,
synaptophysin in 3/19 tumors, chromogranin in 1/22 tumors, WT1
protein in 8/9 tumors, muscle-speciﬁc actin in 3/19 tumors, and
alpha-smooth muscle actin in 3/16 tumors [9]. Lee and Hsiao
observed that all examined DSRCT cells are reactive to cytokeratin,
desmin, vimentin, and WT-1. The EWS-WT1 fusion gene has been
identiﬁed in three patients with DSRCT [10]. Thus, although DSRCT
was initially thought to be of mesodermal origin, due to its sites of
origin, this tumor is now thought to originate from a progenitor celly, left main bronchus and main carina as well as a severe pericardial effusion that is
ible.
Fig. 3. Bronchoscopy revealed a whitish exophytic lesion that almost completely obstructs the left main bronchus.
Fig. 4. Autopsy revealed a tumor mass with large dimensions that weighed 1750 g. The tumor occupied the entire left hemithorax; surrounded and inﬁltrated the left main
bronchus and left great vessels; and was ﬁrmly adhered to the chest wall, diaphragm, pericardium and left atrium wall.
Fig. 5. (A,B) The biopsy revealed a cellular tumor comprising of nests and groups of polygonal to spindle shaped pleomorphic cells, separated by ﬁbrous septa, having high nuclear
to cytoplasmic ratio, high mitosis and some areas of necrosis.
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A diagnosis of DSRCT is supported by the presence in electron
microscopy images of perinuclear whorls of intermediate ﬁlaments,
which correspond to dot-like immunostaining with desmin, in
combination with the pertinent negative ﬁndings of an absence of
specialized cell junctions, neurosecretory granules, and long
microvilli [1,12]. Gerald et al. examined 19 patients with DSRCT and
concluded that this tumor predominantly occurs in the abdomen,
with a mean age of occurrence of 18.4 years and a predilection for
adolescent males [4]. This tumor rarely occurs in females; in female
patients, DSRCT can even be mistaken for ovarian cancer [13]. Ourexamined case was particularly rare because it involved a young
female patient. DSRCT exhibits a characteristic t(11; 22) (p13; q12)
chromosomal translocation that brings the EWS gene on chromo-
some 22 to the WT1 gene on chromosome 11 [3]. In a study by Lae
et al., this translocationwas present in 29/32 examined tumors [14].
Our patient was negative for this chromosomal translocation.
Common manifestations of DSRCT include abdominal pain; a
palpable abdominal mass; abdominal distention due to a mass or
ascites; hydronephrosis due to the obstruction of the urinary tract
by the tumor; intra-abdominal lymphadenopathy; and liver
metastasis [15]. As observed in our patient, who presented with
Fig. 6. Immunohistochemistry indicated that tumor cells were positive for CK7 (A), 34B12 (B), desmin (C) and vimentin (D), conﬁrming the diagnosis of desmoplastic small round
cell tumor.
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depend on the site of the tumor. Contrast-enhanced CT and mag-
netic resonance imaging (MRI) of involved sites reveal that DSRCT is
a mass of heterogeneous density and intensity. Fluorodeoxyglucose
positron emission tomography/CT (FDG-PET/CT) can provide
additional information regarding the stage of DSRCT [16]. The dif-
ferential diagnosis of DSRCT includes small cell mesothelioma,
primitive neuroectodermal tumor (PNET)/Ewing's sarcoma family
tumors, malignant non-Hodgkin's lymphoma and small cell carci-
noma [17].
With respect to the treatment of DSRCT, there have been efforts
to establish treatments to control this disease. One such treatment
combines aggressive surgery, radiation therapy applied to the tu-
mor bed and myeloablative multiagent chemotherapy [18]. A
recent report describing experiences with DSRCT at the Memorial
Sloan-Kettering Cancer Center [5] revealed that overall survival
rates for 66 patients were 44% and 15% at three and ﬁve years,
respectively, after treatment with a combination of the P6 regimen,
surgical debulking and 30 Gy of radiotherapy. However, more than
half of these patients had no distant metastases. At present, there is
no standard therapy for patients with DSRCT, particularly in cases
involving inoperable/metastatic DSRCT, and few reports have
addressed the treatment of metastatic DSRCT [5,6]. Multi-
institutional randomized control trials involving DSRCT are not
available due to the rarity of this disease.
In summary, DSRCT is a rare but aggressive malignancy with a
poor outcome that should be considered in the differential diag-
nosis of undifferentiated small round cell tumors of the thorax. An
aggressive treatment approach that involves multiple modalities
can provide temporary survival beneﬁts for patients with this
disease.
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